Blog
/
Enzyme partners with CV5 Capital to power a new generation of regulated funds
News

Enzyme partners with CV5 Capital to power a new generation of regulated funds

Enzyme is pleased to announce a strategic partnership with CV5 Capital, a leading regulated platform for launching institutional-grade hedge funds and digital asset funds in the Cayman Islands.
18.11.2025
2 min read

Through this collaboration, CV5 Capital is adopting Enzyme Onyx as the foundational technology stack powering the issuance and administration of its tokenized fund offerings.By integrating Onyx across the CV5 Digital SPC umbrella, fund managers can now structure, launch, and operate next-generation investment vehicles, with full regulatory oversight, across a broad range of asset classes, including cryptocurrencies, securities, commodities, and real-world assets such as U.S. Treasuries.

Reinventing regulated fund infrastructure

This partnership combines CV5’s CIMA-regulated Cayman fund architecture with Enzyme’s decentralized, programmable asset management infrastructure, giving managers the ability to issue, structure and administer tokenized hedge funds capable of delivering strategies across any asset class.

“We’re thrilled to collaborate with CV5 Capital in setting a new standard for institutional-grade tokenized funds,” said Mona El Isa, Founder of Enzyme. “Together, we’re making asset management more transparent, efficient, and composable, while preserving the compliance and investor protections institutions rely on.”

David Lloyd, Founder and CEO of CV5 Capital, added: “By integrating Enzyme’s on-chain infrastructure into our regulated framework, we can deliver transparent and compliant fund structures that institutional investors can trust. It’s a significant step toward uniting DeFi and regulated finance.”

What This Means for Fund Managers and Investors

Funds launched under the CV5 Digital SPC umbrella will now benefit from Enzyme Onyx complete Administration tools for granular administration controls across Accounting, Subscription and Fee management.

The partnership will initially support a series of tokenized fund strategies, including market-neutral digital asset products, Bitcoin treasury vehicles, and tokenized credit opportunities.

Looking to launch a Cayman-regulated hedge fund? Contact us now!

Setting a New Benchmark for Tokenized Fund Infrastructure

By combining Enzyme’s on-chain operating system with CV5 Capital’s regulated fund platform, we are building one of the most complete environments available for managers seeking to deploy tokenized hedge funds and digital asset portfolios, with the reliability, governance, and transparency institutions expect.

Stay ahead with Enzyme!

Get the latest updates from Enzyme every month—featuring financial tips, industry insights, and key developments.

Related Articles